Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells

被引:0
|
作者
Jahangir Abdi
Nasrin Rastgoo
Yan Chen
Guo An Chen
Hong Chang
机构
[1] University Health Network,Dept. of Laboratory Hematology, Laboratory Medicine Program, Toronto General Hospital
[2] Nanchang University,Department of Hematology/Oncology, First Affiliated Hospital
[3] University of Toronto,Dept. of Laboratory Medicine & Pathobiology
来源
BMC Cancer | / 19卷
关键词
Bone marrow stroma; Multiple myeloma; Multi-drug resistance; miRNA; Survivin; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 47 条
  • [1] Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
    Abdi, Jahangir
    Rastgoo, Nasrin
    Chen, Yan
    Chen, Guo An
    Chang, Hong
    BMC CANCER, 2019, 19 (01)
  • [2] MIR-101-3P REGULATES BONE MARROW STROMA-INDUCED DRUG RESISTANCE IN MULTIPLE MYELOMA CELLS BY TARGETING SURVIVIN AND MODULATING CELL-CELL ADHESION
    Abdi, J.
    Chen, Y.
    Rastgoo, N.
    Chang, H.
    HAEMATOLOGICA, 2017, 102 : 499 - 500
  • [3] miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5
    Meng, Xin
    Sun, Yanfei
    Liu, Shiying
    Mu, Yanchao
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [4] Upregulation of miR-101-3p Overcomes Ibrutinib Resistance by Targeting ABCC5 in Diffuse Large B-Cell Lymphoma (DLBCL)
    Liu, Mengmeng
    Gao, Hui
    He, Yanxia
    Sun, Xueqing
    Zhang, Lili
    JOURNAL OF HARD TISSUE BIOLOGY, 2023, 32 (01) : 11 - 20
  • [5] Bone Marrow Stromal Cells Induce Bortezomib Resistance in Multiple Myeloma Cells through Downregulation of miRNA-101-3p Targeting Survivin
    Abdi, Jahangir
    Yang, Yijun
    Meyer-Erlach, Patrick
    Chang, Hong
    BLOOD, 2015, 126 (23)
  • [6] Restoration of Mir-138 Expression By Epigenetic Modulation Overcomes Drug Resistance in Multiple Myeloma Cells
    Rastgoo, Nasrin
    Abdi, Jahangir
    Zhang, Lun
    Wang, Minjing
    Chang, Hong
    BLOOD, 2016, 128 (22)
  • [7] Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines
    Nefedova, Y
    Cheng, PY
    Alsina, M
    Dalton, WS
    Gabrilovich, DI
    BLOOD, 2004, 103 (09) : 3503 - 3510
  • [8] Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
    O'Reilly, Eimear
    Dhami, Sukhraj Pal S.
    Baev, Denis V.
    Ortutay, Csaba
    Halpin-McCormick, Anna
    Morrell, Ruth
    Santocanale, Corrado
    Samali, Afshin
    Quinn, John
    O'Dwyer, Michael E.
    Szegezdi, Eva
    SCIENTIFIC REPORTS, 2018, 8
  • [9] Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
    Eimear O’ Reilly
    Sukhraj Pal S. Dhami
    Denis V. Baev
    Csaba Ortutay
    Anna Halpin-McCormick
    Ruth Morrell
    Corrado Santocanale
    Afshin Samali
    John Quinn
    Michael E O’Dwyer
    Eva Szegezdi
    Scientific Reports, 8
  • [10] Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells
    Dimberg, LY
    Dimberg, AI
    Ivarsson, K
    Strömberg, T
    Österborg, A
    Nilsson, K
    Öberg, F
    Wiklund, HJ
    BLOOD, 2005, 106 (04) : 1346 - 1354